Clinical Trial

Safety and Efficacy of a Topical Cream in Mild-to-Moderate Seborrheic Dermatitis

Completed
View on ClinicalTrials.gov →
Summary
A Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the safety and efficacy of scalp cream for Symptom Relief and Microbiome Balance in mild-moderate Seborrheic Dermatitis patients.
Protocol Amendment History 1 change
critical Trial completed 2026-08-01
Trial Details
NCT Number NCT07063615
Lead Sponsor NovoBliss Research Pvt Ltd
Collaborators: Blossom Microbiotics LLC
Conditions Seborrheic Dermatitis
Enrollment 34 participants
Start Date 2025-07-21
Primary Completion 2026-01-10 (estimated)
Study Completion 2026-02-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-10